UMICORE financials
UMICORE
Country: BE Reporting currency: EUR Latest annual report: 2024-12-31
LEI:
529900F3AIQECS8ZSV61 ISIN: BE0974320526 Financial statements
(EUR, as reported — unscaled; 110 line items across 2 annual periods)
| Line item | 2024 | 2023 |
|---|---|---|
| Income statement | ||
| Revenue | €14.85B | €18.27B |
| Other income | €137.2M | €148.5M |
| Operating expenses | €16.25B | €17.82B |
| Employee benefits expense | €996.6M | €981.4M |
| Operating profit (EBIT) | -€1.26B | €590.7M |
| Finance costs | €140.0M | €135.4M |
| Profit before tax | -€1.42B | €482.0M |
| Income tax expense | €107.0M | €104.9M |
| Profit for the year | -€1.53B | €377.1M |
| — attributable to owners | -€1.48B | €385.1M |
| — attributable to NCI | -€51.2M | -€8.0M |
| Total comprehensive income | -€1.59B | €313.0M |
| Cash flow statement | ||
| Cash generated from operations | €966.7M | €1.22B |
| Net cash from operating activities | €868.7M | €1.04B |
| Income taxes paid | €113.9M | €209.3M |
| Net cash from investing activities | -€775.7M | -€948.7M |
| Purchase of PP&E (capex) | €526.1M | €807.5M |
| Purchase of intangibles | €56.1M | €77.3M |
| Net cash from financing activities | €413.5M | €129.3M |
| Dividends paid | €194.2M | €196.2M |
| Proceeds from borrowings | €2.06B | €2.17B |
| Repayments of borrowings | €1.38B | €1.77B |
| Lease liability payments | €21.5M | €20.1M |
| Balance sheet | ||
| Total assets | €9.41B | €9.97B |
| Non-current assets | €3.80B | €4.15B |
| Property, plant & equipment | €2.39B | €3.04B |
| Intangible assets & goodwill | €387.2M | €381.0M |
| Inventories | €2.25B | €2.85B |
| Trade & other receivables | €1.24B | €1.36B |
| Cash & equivalents | €2.01B | €1.52B |
| Total equity | €1.92B | €3.70B |
| — attributable to owners | €1.94B | €3.66B |
| Non-controlling interests | -€16.2M | €36.4M |
| Non-current liabilities | €3.14B | €2.67B |
| Trade & other payables | €2.85B | €2.59B |
| Deferred tax liabilities | €24.7M | €28.7M |
| Derived metrics | ||
| Free cash flow | €342.6M | €235.2M |
| Operating margin | -8.5% | 3.2% |
| Net margin | -10.3% | 2.1% |
| Return on equity | -79.7% | 10.2% |
| Cash conversion ratio | -0.57× | 2.76× |
| Capex coverage | 1.65× | 1.29× |
| Other reported items | ||
| Adjustments For Undistributed Profits of Investments Accounted For Using Equity Method | -€48.6M | €399.0K |
| Bank Overdrafts Classified As Cash Equivalents | €38.6M | €51.7M |
| Basic Earnings Loss Per Share From Continuing Operations | €-6.15 | €1.60 |
| Cash Advances and Loans Made To Other Parties Classified As Investing Activities | €1.6M | €662.0K |
| Cash and Cash Equivalents If Different From Statement of Financial Position | €1.97B | €1.46B |
| Cash Flows From Losing Control of Subsidiaries Or Other Businesses Classified As Investing Activities | €0 | €9.1M |
| Cash Flows Used In Obtaining Control of Subsidiaries Or Other Businesses Classified As Investing Activities | €18.2M | €0 |
| Cash Receipts From Repayment of Advances and Loans Made To Other Parties Classified As Investing Activities | €305.0K | €1.4M |
| Comprehensive Income Attributable To Noncontrolling Interests | -€50.7M | -€9.3M |
| Comprehensive Income Attributable To Owners of Parent | -€1.54B | €322.3M |
| Current Assets Other Than Assets Or Disposal Groups Classified As Held For Sale Or As Held For Distribution To Owners | €5.58B | €5.81B |
| Current Liabilities Other Than Liabilities Included In Disposal Groups Classified As Held For Sale | €4.35B | €3.60B |
| Current Loans and Receivables | €40.0K | €249.0K |
| Current Provisions | €170.0M | €53.0M |
| Current Tax Assets Current | €76.0M | €87.8M |
| Current Tax Liabilities Current | €208.4M | €222.8M |
| Deferred Tax Assets | €378.4M | €370.3M |
| Depreciation Amortisation and Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | €1.72B | €351.1M |
| Diluted Earnings Loss Per Share From Continuing Operations | €-6.15 | €1.60 |
| Dividends Paid To Equity Holders of Parent Classified As Financing Activities | €192.4M | €192.3M |
| Dividends Paid To Noncontrolling Interests Classified As Financing Activities | €1.8M | €3.8M |
| Dividends Received Classified As Operating Activities | €4.0M | €6.1M |
| Dividends Recognised As Distributions To Owners Per Share | €0.80 | €0.80 |
| Effect of Exchange Rate Changes On Cash and Cash Equivalents | €3.6M | €19.2M |
| Equity and Liabilities | €9.41B | €9.97B |
| Finance Income | €44.3M | €34.7M |
| Gains Losses On Cash Flow Hedges Before Tax | -€81.2M | €33.3M |
| Gains Losses On Disposals of Investments | €8.0K | -€5.1M |
| Gains Losses On Exchange Differences On Translation Net of Tax | -€8.8M | -€53.6M |
| Gains Losses On Exchange Differences On Translation Recognised In Profit Or Loss | -€17.9M | -€8.3M |
| Gains Losses On Financial Assets Measured At Fair Value Through Other Comprehensive Income Before Tax | €3.2M | -€7.5M |
| Income Tax Relating To Cash Flow Hedges of Other Comprehensive Income | -€21.1M | — |
| Income Tax Relating To Components of Other Comprehensive Income That Will Be Reclassified To Profit Or Loss | -€21.1M | €9.3M |
| Income Tax Relating To Components of Other Comprehensive Income That Will Not Be Reclassified To Profit Or Loss | €3.4M | -€10.1M |
| Income Tax Relating To Remeasurements of Defined Benefit Plans of Other Comprehensive Income | €3.4M | — |
| Increase Decrease In Cash and Cash Equivalents | €510.1M | €242.5M |
| Increase Decrease In Working Capital | -€391.6M | -€346.5M |
| Increase Decrease Through Changes In Ownership Interests In Subsidiaries That Do Not Result In Loss of Control | — | €10.0K |
| Increase Decrease Through Sharebased Payment Transactions | €6.9M | €14.1M |
| Increase Decrease Through Treasury Share Transactions | — | €2.3M |
| Inflows of Cash From Investing Activities | €1.4M | €20.2M |
| Interest Paid Classified As Financing Activities | €86.5M | €84.7M |
| Investment Accounted For Using Equity Method | €588.5M | €314.7M |
| Liabilities Included In Disposal Groups Classified As Held For Sale | €2.6M | €0 |
| Noncurrent Assets Or Disposal Groups Classified As Held For Sale | €33.9M | €0 |
| Noncurrent Investments Other Than Investments Accounted For Using Equity Method | €22.6M | €19.5M |
| Noncurrent Loans and Receivables | €3.6M | €2.4M |
| Noncurrent Payables | €227.1M | €95.1M |
| Noncurrent Provisions | €265.0M | €214.2M |
| Noncurrent Receivables | €27.3M | €29.7M |
| Noncurrent Recognised Liabilities Defined Benefit Plan | €303.5M | €314.8M |
| Other Adjustments For Noncash Items | €1.88B | €304.9M |
| Other Adjustments For Which Cash Effects Are Investing Or Financing Cash Flow | €181.5M | €188.6M |
| Other Comprehensive Income | -€57.2M | -€64.1M |
| Other Comprehensive Income Before Tax Gains Losses On Remeasurements of Defined Benefit Plans | €12.0M | -€37.2M |
| Other Expense By Nature | €895.8M | €707.3M |
| Outflows of Cash From Investing Activities | €777.0M | €968.9M |
| Proceeds From Sales of Intangible Assets Classified As Investing Activities | €101.0K | €0 |
| Proceeds From Sales of Property Plant and Equipment Classified As Investing Activities | €893.0K | €9.7M |
| Proceeds From Sales Or Maturity of Financial Instruments Classified As Investing Activities | €81.0K | €0 |
| Profit Loss From Continuing Operations | -€1.53B | €377.1M |
| Purchase of Financial Instruments Classified As Investing Activities | €0 | €4.6M |
| Purchase of Interests In Investments Accounted For Using Equity Method | €175.0M | €78.9M |
| Retained Earnings | €1.07B | €2.72B |
| Revenue and Operating Income | €14.99B | €18.41B |
| Share of Profit Loss of Associates and Joint Ventures Accounted For Using Equity Method | -€48.6M | €399.0K |
| Statutory Reserve | €55.0M | — |
| Treasury Shares | €260.0M | €261.6M |
Methodology
Every line item above is a fact tagged in UMICORE's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (EUR), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.